《美股業績》工業原材料商杜邦(DD.US)指中國原料供應受阻 廠房須放緩生產
美國工業原材料生產商杜邦(DD.US)公佈首季業績。季度純利4.88億美元,按年跌91%,受業務出售收益減少影響。每股季度攤薄純利95美仙。季度淨銷售32.74億美元,按年升9%,略遜市場預期,季度持續經營收益2.32億美元,按年跌40%。
公司預期現季度銷量增長放緩,毛利率將按季收縮,受中國新冠防疫對供應鏈構成進一步壓力影響。公司指,電子業務中部分來自中國的重要原材料,公司未獲全面供應,部分廠房要放慢生產。
公司亦稱季內已上調產品價格6%以銷原材料及能源成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.